Parize P, Mainardi J-L
Unité mobile de microbiologie clinique, service de microbiologie, hôpital européen Georges-Pompidou, université Paris Descartes, 20, rue Leblanc, 75908 Paris cedex, France.
Rev Med Interne. 2011 Oct;32(10):612-21. doi: 10.1016/j.revmed.2010.10.007. Epub 2010 Nov 19.
Infective endocarditis has continuously evolved since its first clinical description by William Osler in the late 19th century. The epidemiological and microbiological profile of the disease has changed as the result of the progress of the medical care and demographic mutation in industrialized countries. Furthermore, advances in anti-infective therapy and in cardiovascular surgery have contributed to an improvement in the management and the prognosis of this severe infectious disease. During the past decade, the recommendations on antibiotic prophylaxis against infective endocarditis have changed dramatically. Guidelines on management of infective endocarditis and state-of-the-art articles have been published recently and this work aims to outline current recommendations about this evolving disease.
自19世纪末威廉·奥斯勒首次对感染性心内膜炎进行临床描述以来，该病一直在不断演变。由于工业化国家医疗保健的进步和人口结构的变化，该病的流行病学和微生物学特征已发生改变。此外，抗感染治疗和心血管外科手术的进展有助于改善这种严重传染病的管理和预后。在过去十年中，关于预防感染性心内膜炎的抗生素建议发生了巨大变化。最近已发表了感染性心内膜炎管理指南和最新的文章，这项工作旨在概述关于这种不断演变的疾病的当前建议。
